SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-002449
Filing Date
2024-01-29
Accepted
2024-01-29 16:21:59
Documents
3
Period of Report
2024-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1706563309.html 3  
1 FORM 3 wk-form3_1706563309.xml 3 1684
2 EX-24.POALEFFLER leffler-powerofattorneyd.htm EX-24.POALEFFLER 4328
3 GRAPHIC leffler-powerofattorneyd001.jpg GRAPHIC 238251
  Complete submission text file 0001628280-24-002449.txt   335752
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O CLOVER HEALTH INVESTMENTS, CORP. 3401 MALLORY LANE, SUITE 210 FRANKLIN TN 37067
Business Address
Leffler Scott J. (Reporting) CIK: 0001832406 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 24573943